Tenax Therapeutics (TENX) Shares Issued (2013 - 2026)
Tenax Therapeutics (TENX) posted quarterly Shares Issued of $7.9 million for Q2 2026, up 30.4% year-over-year from $6.1 million in Q2 2025, and little changed on a QoQ basis from $7.9 million in Q1 2026.
Tenax Therapeutics (TENX) Shares Issued (2013 - 2026) Analysis & Trends
Tenax Therapeutics has reported Shares Issued for 12 years, with the latest figure at $7.9 million in Q2 2026.
- Shares Issued for Q2 2026 came in at $7.9 million, up 30.4% year-over-year; the trailing twelve-month figure through Jun 2026 was $7.9 million (up 30.4% YoY), and the FY2025 annual result was $6.6 million, up 111.63% from the prior year.
- Shares Issued held at $7.9 million in Q2 2026, from $7.9 million in the prior quarter.
- Over five years, Shares Issued peaked at $7.9 million in Q2 2026 and troughed at $646.0 in Q4 2023.
- A 5-year average of $4.6 million and a median of $6.1 million in 2025 frame the typical range for Shares Issued.
- The widest annual swing landed in 2023, when Shares Issued slipped 4.86%; it then jumped 483868.42% in 2024.
- A 5-year view of Shares Issued shows it stood at $679.0 in 2022, then dropped by 4.86% to $646.0 in 2023, then jumped by 483868.42% to $3.1 million in 2024, then surged by 111.63% to $6.6 million in 2025, then rose by 19.36% to $7.9 million in 2026.
- Per Business Quant data, the three most recent Shares Issued figures were $7.9 million in Q2 2026, $7.9 million in Q1 2026, and $6.6 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Tenax Therapeutics | 78.47 Mn | 78.47 Mn | - | 7.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 7.90 Mn |
| Jun 30, 2026 | 7.90 Mn |
| Mar 31, 2026 | 7.87 Mn |
| Mar 31, 2026 | 7.87 Mn |
| Dec 31, 2025 | 6.62 Mn |
| Dec 31, 2025 | 6.62 Mn |
| Sep 30, 2025 | 6.46 Mn |
| Sep 30, 2025 | 6.46 Mn |
| Jun 30, 2025 | 6.06 Mn |
| Jun 30, 2025 | 6.06 Mn |
| Mar 31, 2025 | 482.00 |
| Mar 31, 2025 | 482.00 |
| Dec 31, 2024 | 3.13 Mn |
| Dec 31, 2024 | 3.13 Mn |
| Dec 31, 2023 | 646.00 |
| Dec 31, 2023 | 646.00 |
| Dec 31, 2022 | 679.00 |
| Dec 31, 2022 | 679.00 |
| Dec 31, 2019 | 244,206.00 |
| Dec 31, 2019 | 244,206.00 |